Toby Maher

University of Southern California Keck School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Elisabeth Bendstrup

Aarhus University

DENMARK

View details

Vanessa Smith

Ghent University Hospital

BELGIUM

View details

Francesco Bonella

GERMANY

View details

Matthew Maddocks

King’s College London

UNITED KINGDOM

View details

David Zhang

Assistant Professor

Columbia University Irving Medical Center

UNITED STATES

View details

Luca Richeldi

Università Cattolica del Sacro Cuore

ITALY

View details

Claudia Valenzuela

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Toby Maher

Research Interests

Explore related searches

Contact this professor

Articles (11)

Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study

Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)

Gazing into the Proteomic Crystal Ball: Predicting Survival in Idiopathic Pulmonary Fibrosis

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis

Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease

Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry

A clinical short‐cut to identifying short telomeres in idiopathic pulmonary fibrosis?

Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice

Collaborators (7)

Elisabeth Bendstrup

Vanessa Smith

Francesco Bonella

Matthew Maddocks

David Zhang

Luca Richeldi

Claudia Valenzuela

Make your next move.